Calcium Salt of N-(5-Hydroxynicotinoyl)-L-Glutamic Acid Weakens Depressive-Like Behavior and Parkinsonian Syndrome in Experiment on Rodents

Bull Exp Biol Med. 2019 Nov;168(1):48-51. doi: 10.1007/s10517-019-04643-5. Epub 2019 Nov 19.

Abstract

We studied antidepressant and antiparkinsonian properties of N-(5-hydroxynicotinoyl)-Lglutamic acid calcium salt (Ampasse) in rodents. It was found that Ampasse in a dose of 30 mg/kg exhibited antidepressant activity in the forced swimming test in mice and in a dose of 0.1 mg/kg maximally alleviates the symptoms of parkinsonian syndrome induced by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57Bl/6 mice, and haloperidol-induced catalepsy in rats.

Keywords: antidepressant; gliocyte; neurodegeneration; parkinsonian syndrome; rodents.

MeSH terms

  • Animals
  • Antidepressive Agents / therapeutic use*
  • Calcium / chemistry*
  • Catalepsy / chemically induced
  • Depression / drug therapy*
  • Glutamic Acid / chemistry*
  • Glutamic Acid / therapeutic use*
  • Haloperidol / pharmacology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Parkinsonian Disorders / drug therapy*

Substances

  • Antidepressive Agents
  • Glutamic Acid
  • Haloperidol
  • Calcium